CERTARA™
Model-Based Development Strategies
Pharsight's global Consulting Services team is committed to advancing drug development efficiency and decision-making through the application of novel methods, integrated approaches, and enabling technology.
Our team has particular expertise in the following areas:
- Special Populations: Pediatrics
- Drug Safety: Concentration-QTc Modeling
- Product Profile Assesment: Clinical Utility Index® (CUI®) Modeling
- PK-Based Formulation Strategy: IVIVC Applications
- Decision Support for In-Licensing: "Model-Based Due Diligence"
